Trial intelligence / Profile preview

Aminophylline for facilitating weaning from mechanical ventilation in brain-injured patients

IRCT20170608034390N16Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of aminophylline in traumatic brain injury (TBI), sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2025; status: completed.

02

Drugs

aminophylline
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on IRCT20170608034390N16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170608034390N16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call